E. Coli Testing Market is Projected to Rise at a CAGR of 8.0% from 2017 to 2025

Posted November 2, 2017 by hawerr

E. Coli Testing Market report categorizes the global market by Testing Method (Membrane Filtration and Multiple Tube Fermentation, Polymerase Chain Reaction

The global E. coli testing market was valued at US$1.18 bn in 2016 and is projected to rise at a CAGR of 8.0% from 2017 to 2025. Expanding at this pace, the opportunities in the market is anticipated to reach US$2.36 bn by the end of the forecast period. The growing incidence of hospital- and community- acquired urinary tract infections caused by E. coli and related morbidity of the infections in various populations are the key factors driving the market. World over, the rising prevalence of antimicrobial resistance among E. coli is a growing concern, paving the way for abundant growth opportunities in the market in the coming years. In recent years, the growing instances of antibiotic susceptibility of E. coli against commonly prescribed antibiotics, such as penicillin and amoxicillin, has offered a shot in the arm for the vendors in the E. coli testing market. The growing prevalence of various water and food-borne diseases, such as diarrhea and hemolytic uremic syndrome, in various nations, particularly in underdeveloped and low-income nations, has led to the demand for E. coli testing methods, catalyzing the market.

Browse Report [email protected] https://www.transparencymarketresearch.com/e-coli-testing-market.html

Governments and regulatory agencies in numerous countries in developed regions, such as various parts of North America and Europe, are increasingly adopting preventive measures to prevent any epidemic caused due to growing number of drug-resistant E. coli. This has accentuated the growth of the E. coli market. For instance, Environment Protection Agencies (EPA) has laid down guidelines for water bodies infected by the bacteria exceeding the levels fixed by bacteriological standards. This has positively affected the growth of the market.

Regionally, the global E. coli testing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2016, North America held the dominant share of nearly 44.5% in the global E. coli testing market. North America has been one of the early adopters of the latest technologies. Besides this, the region also boasts a sophisticated healthcare infrastructure, which is aiding the growth of the E. coli testing market.

Meanwhile, the Europe market is saturated and growing at slow rate while Asia Pacific is anticipated to witness the fastest CAGR during the forecast period with major contribution of countries such as India, Japan and China. New product launches, favorable regulations, ability of patients to pay for advanced technology products, and growing awareness are likely to drive the market in Asia Pacific during the forecast period.

Report Overview, with TOC - https://www.transparencymarketresearch.com/report-toc/4822

Some of the key players operating in the E. coli testing market are IDEXX Laboratories, Inc., Meridian Bioscience, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., CPI International, Inc., Bio-Rad Laboratories, Inc., Pro-Lab Diagnostics, Inc., Alere Inc., BioMerieux Inc., and NanoLogix, Inc.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Country United States
Categories Biotech , Medical , Research
Tags E. Coli Testing Market
Last Updated November 2, 2017